Annual Reports

Speeches, letters, Presentations

Annual Meeting Archive

Economic Development

• NYS Comptroller Report: The Economic Impact of the Biotechnology and Pharmaceutical Industries in New York
• NYBA Position Statement to NYS Leadership
• NYBA Testimony to NYS Senate NextGen Task Force on Biotech Industry Development
• Position Paper -- A Plan for Creating a World-Class Biotechnology Industry in New York
• Testimony to Assembly committee on Economic Development

Industry-focused Tax Incentives (NYS)

• Nassau Senate Delegation Highlights New State Incentives To Create High-Tech And Biotech Jobs
• QETC Primer
• NYSTAR: New York State Tax Credits for High-Tech Companies
• QETC-Instruction Form

NYS Programs for Industry Growth

• GEN*NY*SIS
• JOBS Agenda 2001

GMOs (Genetically Modified Organisms)

• MEMORANDUM IN OPPOSITION OF BILLS S.6625 / A.8344:
  Mandatory Labeling Requirements for Seeds that Contain Genetically Modified Organisms
• Letter to NYS Assembly
• Testimony to NYS Senate

Intellectual Property

• Hatch-Waxman Reform - Letter to Senator Schumer

SBIR (Small Business Innovative Research Program)

• Letter to NY Congressional Delegation

Stem Cells/Cloning

• Letter to Senator Clinton - Therapeutic Cloning Act
• Letter to NYS Senate regarding support of The Reproductive Cloning Prohibition and Research Protection Act (S3013-A)
• NYBA press release regarding New York State Assembly Passage of Therapeutic Stem Cell Legislation
• Comment on President's Statement on Stem Cell Research

REIMBURSEMENT ISSUES

• Federal Issue: Importation of Drugs from Canada and other Countries
  Letter to U.S. Senator Hillary Clinton opposing proposed federal legislation that would legalize drug importation from Canada.
• State Issue: Preferred Drug Program (PDP) and Pharmaceutical Price Controls
  Letter to Governor Pataki opposing proposed state legislation that would create a Preferred Drug Program in the New York Medicaid program.
• NYBA Position Statement on Drug Reimbursment
• Letter to Governor George Pataki

Biotech Industry Background

BIO- Biotechnology Industry Facts


Proposed 2011 Bylaws Revisions